BRAF and melanoma: Long Long GV GV Stroyakovskiy Stroyakovskiy D D Gogas Gogas H H Levchenko Levchenko E E de Braud de Braud F F Larkin Larkin J J Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial Lancet Lancet 2015 2015 386 386 9992 9992 444 444 451 451 10.1016/S0140-6736(15)60898-4 10.1016/S0140-6736(15)60898-4 26037941 26037941